+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

GlaxoSmithkline Consumer Healthcare Ltd - Strategy, SWOT and Corporate Finance Report

GlaxoSmithkline Consumer Healthcare Ltd - Strategy, SWOT and Corporate Finance Report

Summary

GlaxoSmithkline Consumer Healthcare Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GlaxoSmithKline Consumer Healthcare Ltd (GSKCH), a subsidiary of GlaxoSmithKline plc is a manufacturer and marketer of health food drinks. The company's product portfolio comprise of health drinks, oats, biscuits, calcium supplement, noodles, digestive health products, pain relief balms and drugs, cold and flu drugs and nasal decongestant, toothpaste and tooth brush, prescribed medicines and vaccines. GSKCH offers its products under the brand names Horlicks, Boost, Ostocalcium, Viva, Maltova, Eno, Crocin, Iodex, Otrivin and Sensodyne. The company sells its products through marketing and distribution network such as distributors, retail outlets and sub distributors. It operates manufacturing facilities in Nabha, Sonepat and Rajahmundry in India. GSKCH is headquartered in Gurgaon, Haryana, India.

Scope

  • Detailed information on GlaxoSmithkline Consumer Healthcare Ltd required for business and competitor intelligence needs.
  • A study of the major internal and external factors affecting GlaxoSmithkline Consumer Healthcare Ltd in the form of a SWOT analysis.
  • An in-depth view of the business model of GlaxoSmithkline Consumer Healthcare Ltd including a breakdown and examination of key business segments.
  • Intelligence on GlaxoSmithkline Consumer Healthcare Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors.
  • News about GlaxoSmithkline Consumer Healthcare Ltd, such as business expansion, restructuring, and contract wins.
  • Large number of easy-to-grasp charts and graphs that present important data and key trends.

Reasons to Buy

  • Gain an understanding of GlaxoSmithkline Consumer Healthcare Ltd and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess GlaxoSmithkline Consumer Healthcare Ltd as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on GlaxoSmithkline Consumer Healthcare Ltd's business structure, strategy and prospects.

Table of Contents

  • Company Snapshot
  • GlaxoSmithkline Consumer Healthcare Ltd: Company Overview
  • GlaxoSmithkline Consumer Healthcare Ltd: Overview and Key Facts
  • GlaxoSmithkline Consumer Healthcare Ltd: Overview
  • GlaxoSmithkline Consumer Healthcare Ltd: Key Facts
  • GlaxoSmithkline Consumer Healthcare Ltd: Key Employees
  • GlaxoSmithkline Consumer Healthcare Ltd: Key Employee Biographies
  • GlaxoSmithkline Consumer Healthcare Ltd: Major Products and Services
  • GlaxoSmithkline Consumer Healthcare Ltd: Company History
  • GlaxoSmithkline Consumer Healthcare Ltd: Management Statement
  • GlaxoSmithkline Consumer Healthcare Ltd: Locations and Subsidiaries
  • GlaxoSmithkline Consumer Healthcare Ltd: Key Competitors
  • GlaxoSmithkline Consumer Healthcare Ltd: Company Analysis
  • GlaxoSmithkline Consumer Healthcare Ltd: Business Description
  • GlaxoSmithkline Consumer Healthcare Ltd: SWOT Analysis
  • GlaxoSmithkline Consumer Healthcare Ltd: SWOT Overview
  • GlaxoSmithkline Consumer Healthcare Ltd: Strengths
  • GlaxoSmithkline Consumer Healthcare Ltd: Weaknesses
  • GlaxoSmithkline Consumer Healthcare Ltd: Opportunities
  • GlaxoSmithkline Consumer Healthcare Ltd: Threats
  • GlaxoSmithkline Consumer Healthcare Ltd: Corporate Financial Deals Activity
  • GlaxoSmithkline Consumer Healthcare Ltd: Financial Deals Overview
  • GlaxoSmithkline Consumer Healthcare Ltd: Targets and Partners
  • GlaxoSmithkline Consumer Healthcare Ltd: Top Deals 2016-2020YTD*
  • GlaxoSmithkline Consumer Healthcare Ltd: Advisors
  • GlaxoSmithkline Consumer Healthcare Ltd: Top Legal Advisors
  • GlaxoSmithkline Consumer Healthcare Ltd: Top Financial Advisors
  • GlaxoSmithkline Consumer Healthcare Ltd: Mergers and Acquisitions
  • GlaxoSmithkline Consumer Healthcare Ltd: Partnership
  • GlaxoSmithkline Consumer Healthcare Ltd: Divestments
  • GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership
  • GlaxoSmithkline Consumer Healthcare Ltd: Recent Developments
  • GlaxoSmithkline Consumer Healthcare Ltd: News and Events Summary
  • GlaxoSmithkline Consumer Healthcare Ltd: Business Expansion
  • GlaxoSmithkline Consumer Healthcare Ltd: Contracts
  • GlaxoSmithkline Consumer Healthcare Ltd: Financial Deals
  • GlaxoSmithkline Consumer Healthcare Ltd: Financial Performance
  • GlaxoSmithkline Consumer Healthcare Ltd: Market Developments
  • GlaxoSmithkline Consumer Healthcare Ltd: Strategy and Operations
  • Appendix
  • Contact Us
  • Methodology
  • About the Author

List of Tables
Table 1: GlaxoSmithkline Consumer Healthcare Ltd: Key Facts
Table 2: GlaxoSmithkline Consumer Healthcare Ltd: Key Employees
Table 3: GlaxoSmithkline Consumer Healthcare Ltd: Company History
Table 4: GlaxoSmithkline Consumer Healthcare Ltd: Locations and Subsidiaries
Table 5: GlaxoSmithkline Consumer Healthcare Ltd: Key Competitors
Table 6: GlaxoSmithkline Consumer Healthcare Ltd: Deal Activity by Deal Type-Volume (TTM*)
Table 7: GlaxoSmithkline Consumer Healthcare Ltd: M&A Activity by Geography (TTM*)
Table 8: GlaxoSmithkline Consumer Healthcare Ltd: Deal Activity by Deal Type-Volume (2016-YTD*2020)
Table 9: GlaxoSmithkline Consumer Healthcare Ltd: M&A Average Deal Size-Value (US$m)
Table 10: GlaxoSmithkline Consumer Healthcare Ltd: Targets and Partners
Table 11: GlaxoSmithkline Consumer Healthcare Ltd: Top Deals 2016-2020YTD*
Table 12: GlaxoSmithkline Consumer Healthcare Ltd: Legal Advisor Ranking by Value (US$m)
Table 13: GlaxoSmithkline Consumer Healthcare Ltd: Financial Advisor Ranking by Value (US$m)
Table 14: GlaxoSmithkline Consumer Healthcare Ltd: M&A Volume and Value Trend (2016-YTD*2020)
Table 15: GlaxoSmithkline Consumer Healthcare Ltd: Partnership Volume and Value Trend (2016-YTD*2020)
Table 16: GlaxoSmithkline Consumer Healthcare Ltd: Partnership Trend by Deal Type (2016-YTD*2020)
Table 17: GlaxoSmithkline Consumer Healthcare Ltd: Divestments Volume and Value Trend (2016-YTD*2020)
Table 18: GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership Volume and Value Trend (2016-YTD*2020)
Table 19: GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership Volume by Deal Type (2016-YTD*2020)
Table 20: GlaxoSmithkline Consumer Healthcare Ltd: News and Events Summary
Table 21: GlaxoSmithkline Consumer Healthcare Ltd: Business Expansion
Table 22: GlaxoSmithkline Consumer Healthcare Ltd: Contracts
Table 23: GlaxoSmithkline Consumer Healthcare Ltd: Financial Deals
Table 24: GlaxoSmithkline Consumer Healthcare Ltd: Financial Performance
Table 25: GlaxoSmithkline Consumer Healthcare Ltd: Market Developments
Table 26: GlaxoSmithkline Consumer Healthcare Ltd: Strategy and Operations

List of Figures
Figure 1: GlaxoSmithkline Consumer Healthcare Ltd: Deal Activity by Deal Type-Volume (TTM*)
Figure 2: GlaxoSmithkline Consumer Healthcare Ltd: M&A Activity by Geography (TTM*)
Figure 3: GlaxoSmithkline Consumer Healthcare Ltd: Deal Activity by Deal Type-Volume (2016-YTD*2020)
Figure 4: GlaxoSmithkline Consumer Healthcare Ltd: M&A Average Deal Size-Value (US$m)
Figure 5: GlaxoSmithkline Consumer Healthcare Ltd: M&A Volume and Value Trend (2016-YTD*2020)
Figure 6: GlaxoSmithkline Consumer Healthcare Ltd: Partnership Volume and Value Trend (2016-YTD*2020)
Figure 7: GlaxoSmithkline Consumer Healthcare Ltd: Partnership Trend by Deal Type (2016-YTD*2020)
Figure 8: GlaxoSmithkline Consumer Healthcare Ltd: Divestments Volume and Value Trend (2016-YTD*2020)
Figure 9: GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership Volume and Value Trend (2016-YTD*2020)
Figure 10: GlaxoSmithkline Consumer Healthcare Ltd: Private Equity and Ownership Volume by Deal Type (2016-YTD*2020)